Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Sep 18, 2025 3:59:56 PM EDT

221.97USD+0.525%(+1.16)4,408,666

221.91Bid 222.02Ask 0.11Spread

Pre-market

Sep 18, 2025 8:44:30 AM EDT

219.62USD-0.540%(-1.19)556

After-hours

Sep 18, 2025 4:53:30 PM EDT

221.99USD+0.009%(+0.02)124,919

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

391.70B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Nov 5, 2025 (48d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

4,788,009

Avg. Vol. 30 Day

4,540,130

Employees

30,000

Market Cap

391,701,434,619

Shares Out.

1,766,558,253

On/Off Exchange

54%/46%

6 Month Beta

0.55

1 Year Beta

0.42

2 Year Beta

0.38

3 Year Beta

0.36

52 Week Low

163.81

52 Week High

221.77

SMA50

201.64

SMA200

191.42

1 Week

+0.69%

1 Month

+7.34%

3 Month

+19.54%

6 Month

+3.69%

1 Year

+14.92%

2 Year

+44.04%

5 Year

+146.07%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $221.97, and today's volume is 4,408,666. ABBV is up 0.525% today. The 30 day average volume is 4,540,130. ABBV market cap is 391.70B with 1,766,558,253 shares outstanding.

document.getElementById("dhqmfK").onerror = function(){this.style.display='none';}; .dark-mode .FSNhzK{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .FSNhzK{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE